Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
Moderna (MRNA) Sues Pfizer and BioNTech Over COVID Jab
03:37pm, Monday, 29'th Aug 2022 Zacks Investment Research
Moderna (MRNA) sues Pfizer and BioNTech, alleging that Comirnaty infringes on patents that Moderna filed from 2010 to 2016 related to its mRNA technology.
Do Options Traders Know Something About BioNTech (BNTX) Stock We Don't?
12:42pm, Monday, 29'th Aug 2022 Zacks Investment Research
Investors need to pay close attention to BioNTech (BNTX) stock based on the movements in the options market lately.
Could This Move by Moderna Cost Pfizer Billions?
10:00am, Sunday, 28'th Aug 2022 The Motley Fool
Moderna's complaint is focused on two critical innovations.
Could This Move by Moderna Cost Pfizer Billions?
06:00am, Sunday, 28'th Aug 2022
Moderna's complaint is focused on two critical innovations.
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
01:20pm, Saturday, 27'th Aug 2022 MarketWatch
Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE, alleging the pair infringed patents relating to its mRNA platform, a key technology behind all of their COVID
Moderna sues Pfizer and BioNTech
08:15pm, Friday, 26'th Aug 2022
CNBC's Shep Smith reports on a lawsuit filed by Moderna against Pfizer and BioNTech for patent infringement.
Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
04:01pm, Friday, 26'th Aug 2022 MarketWatch
Some 16 million Americans of working age have long-term COVID and about 2 to 4 million are not working as they struggle with their symptoms, according to a new report from the Brookings Institution.
Moderna Sues Pfizer Over mRNA Technology Used in COVID Vaccines
03:13pm, Friday, 26'th Aug 2022
Moderna is suing Pfizer and BioNTech over patents it said it filed years ago on the life-saving technology.
Moderna sues Pfizer, BioNTech over alleged mRNA patent infringement
02:29pm, Friday, 26'th Aug 2022
Moderna filed a lawsuit against Pfizer and BioNTech claiming the biopharmaceutical companies infringed on Moderna's patents related to mRNA technology in develop of their COVID-19 vaccine. The lawsuit
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
01:45pm, Friday, 26'th Aug 2022 GlobeNewswire Inc.
NEW YORK and MAINZ, GERMANY, August 26, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for a bo
Pfizer und BioNTech vervollständigen Zulassungsantrag für an Omikron BA.4/BA.5 angepassten bivalenten Impfstoff an die Europäische Arzneimittel-Agentur
01:45pm, Friday, 26'th Aug 2022 GlobeNewswire Inc.
NEW YORK und MAINZ, Deutschland, 26. August 2022 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute bekannt, dass sie bei der Europäischen Arzneimitt
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
01:41pm, Friday, 26'th Aug 2022
Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE, alleging the pair infringed patents relating to its mRNA platform, a key technology behind all of their COVID
Moderna sues Pfizer, BioNTech over COVID vaccine patent
10:33am, Friday, 26'th Aug 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Moderna's decision to sue rival vaccine maker Pfizer over the delivery technology used in COVID-19 vaccines.
Report finds Americans losing up to $1 billion in wages from long COVID, and Moderna sues Pfizer and BioNTech over mRNA patents
10:04am, Friday, 26'th Aug 2022
Some 16 million Americans of working age have long-term COVID and about 2 to 4 million are not working as they struggle with their symptoms, according to a new report from the Brookings Institution.
Moderna sues Pfizer and BioNTech for patent infringement over COVID vaccine
09:52am, Friday, 26'th Aug 2022
Moderna alleges Pfizer and its German partner BioNTech copied their mRNA technology while developing their COVID-19 vaccine.
